Quality & complianceOfficial

Denmark flags supply problems with Paranova's NorLevo emergency contraceptive tablets

🇩🇰 DKMA · Fri 13 Nov 2026

The Danish Medicines Agency reports delivery difficulties with NorLevo 1.5 mg tablets from Paranova Danmark ApS, with no end date given.

The Danish Medicines Agency (DKMA) has published a supply notice for NorLevo 1.5 mg tablets marketed by Paranova Danmark ApS. The notice, dated 13 November 2026, says there are current problems with the supply of the product.

NorLevo contains levonorgestrel (ATC code G03AD01), the active substance in this emergency contraceptive. DKMA gives the cause as delivery difficulties and does not elaborate further.

The agency lists the expected period of disruption as starting in mid-October 2026, with the end date unknown. The notice does not say which pack sizes are affected, whether alternatives are available or how supply will be restored.

DKMA directs questions about the current status to the company. The notice appears in the agency's section for announcements on the supply of medicines.

What it means for your team

  • Supply-chain and market-access teams in Denmark should check stock and order status for NorLevo 1.5 mg with Paranova, which DKMA names as the contact for current status.
  • Because the disruption has no stated end date, teams may want to monitor DKMA's supply announcements for updates.
  • PV and medical information teams should be aware of the shortage in case of enquiries about access to levonorgestrel emergency contraception; the notice does not mention any safety concern.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.

More Quality & compliance All →